Abstract
Objectives: While 75-90% of people who develop lung cancer are smokers, only a small proportion of smokers develop lung cancer. Identifying factors that increase a smoker's risk of developing lung cancer may help scientists to better understand the etiology of lung cancer and more effectively target high-risk groups for screening.
Methods: Information on physician-diagnosed non-malignant lung diseases [asbestosis, asthma, chronic bronchitis or emphysema (CB/E), pneumonia, and tuberculosis] was obtained at baseline from 17,698 men and women involved in CARET, a randomized lung cancer prevention trial of beta-carotene and vitamin A among heavy smokers and asbestos-exposed workers. Hazard ratios for lung cancer were estimated through Cox regression models, after controlling for potential confounding factors, included smoking. Analyses were restricted to former and current smokers.
Results: During a median follow up of 9.1 years, 1028 cases of lung cancer occurred. Those who developed lung cancer were more likely to report a history of CB/E than controls (adjusted HR = 1.29, 95% CI: 1.09-1.53). In subgroup analyses, the association between a history of CB/E and lung cancer was stronger for those who were younger at diagnosis/reference, men in the heavy smoker cohort, former smokers, and those with squamous cell carcinomas. There was little association between a history of other lung diseases and lung cancer.
Conclusions: Smokers with a history of CB/E may be at higher risk of developing lung cancer, independent of their smoking history.
Similar content being viewed by others
References
Blot WJ, Fraumeni JF Jr (1996)Cancers of the lung and pleura.In:Fraumeni JF,Jr ed.Cancer Epidemiology and Prevention.Oxford: Oxford University Press,pp.637-665.
Osann KE, Lowery JT, Schell MJ (2000)Small cell lung cancer in women:risk associated with smoking,prior respiratory disease, and occupation.Lung Cancer 28:1-10.
Brownson RC, Alavanja MC (2000)Previous lung disease and lung cancer risk among women (United States).Cancer Causes Control 11:853-858.
Mayne ST, Buenconsejo J, Janerich DT (1999)Previous lung disease and risk of lung cancer among men and women nonsmok-ers.Am J Epidemiol 149:13-20.
Wu AH, Fontham ET, Reynolds P,et al.(1995)Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.Am J Epidemiol 141:1023-1032.
Wu-Williams AH, Dai XD, Blot W,et al.(1990)Lung cancer among women in north-east China.Br J Cancer 62:982-987.
Samet JM, Humble CG, Pathak DR (1986)Personal and family history of respiratory disease and lung cancer risk.Am Rev Respir Dis 134:466-470.
Alavanja MC, Brownson RC, Boice JD Jr, Hock E (1992) Preexisting lung disease and lung cancer among nonsmoking women.Am J Epidemiol 136:623-632.
Islam SS, Schottenfeld D (1994)Declining FEV1 and chronic productive cough in cigarette smokers:a 25-year prospective study of lung cancer incidence in Tecumseh,Michigan.Cancer Epidemiol Biomarkers Prev 3:289-298.
Sasco AJ, Merrill RM, Dari I,et al.(2002)A case-control study of lung cancer in Casablanca,Morocco.Cancer Causes Control 13:609-616.
Ger LP, Hsu WL, Chen KT, Chen CJ (1993)Risk factors of lung cancer by histological category in Taiwan.Anticancer Res 13: 1491-1500.
Omenn GS, Goodman G, Thornquist M,et al.(1996)Chemoprevention of lung cancer:the beta-Carotene and Retinol Ecacy Trial (CARET)in high-risk smokers and asbestos-exposed workers.IARC Sci Publ:67-85.
Omenn GS, Goodman GE,Thornquist MD,et al.(1996)Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease.N Engl J Med 334:1150-1155.
Ferris BG (1978)Epidemiology Standardization Project (American Thoracic Society).Am Rev Respir Dis 118:1-120.
Bobadilla A, Guerra S, Sherrill D, Barbee R (2002)How accurate is the self-reported diagnosis of chronic bronchitis?Chest 122: 1234-1239.
Omenn GS, Goodman GE, Thornquist MD,et al.(1993)The Carotene and Retinol Ecacy Trial (CARET)to prevent lung cancer in high-risk populations:pilot study with asbestos-exposed workers.Cancer Epidemiol Biomarkers Prev 2:381-387.
Crapo RO, Morris AH, Gardner RM (1981)Reference spirometric values using techniques and equipment that meet ATS recommen-dations.Am Rev Respir Dis 123:659-664.
Fritz AG (2000)International Classi cation of Diseases for Oncology:ICD-O.World Health Organization,Geneva.
Hosmer DW, Lemeshow S (1999)Applied Survival Analysis: Regression Modeling of Time to Event Data.Wiley, New York.
Albanes D, Heinonen OP, Taylor PR,et al.(1996)Alpha-tocopherol and beta-carotene supplements and lung cancer inci-dence in the alpha-tocopherol,beta-carotene cancer prevention study:effects of base-line characteristics and study compliance.J Natl Cancer Inst 88:1560-1570.
Surveillance,Epidemiology,and End Results (SEER)Program (www.seer.cancer.gov).Incidence-SEER 9 Regs Public-Use,Nov 2002 Sub (1973-2000).National Cancer Institute,DCCPS,Sur-veillance Research Program,Cancer Statistics Branch.
Brenner AV, Wang Z, Kleinerman RA,et al.(2001)Previous pulmonary diseases and risk of lung cancer in Gansu Province, China.Int J Epidemiol 30:118-124.
Gao YT, Blot WJ, Zheng W,et al.(1987)Lung cancer among Chinese women.Int J Cancer40:604-609.
Ko YC, Lee CH, Chen MJ,et al.(1997)Risk factors for primary lung cancer among non-smoking women in Taiwan.Int J Epidemiol 26:24-31.
Kreuzer M, Gerken M, Kreienbrock L, Wellmann J, Wichmann HE (2001)Lung cancer in lifetime nonsmoking men-results of a case-control study in Germany.Br J Cancer 84:134-140.
Kreuzer M, Heinrich J, Kreienbrock L, Rosario AS, Gerken M, Wichmann HE (2002)Risk factors for lung cancer among nonsmoking women.Int J Cancer 100:706-713.
Kubik AK, Zatloukal P, Tomasek L, Petruzelka L (2002)Lung cancer risk among Czech women:a case-control study.Prev Med 34:436-444.
Osann KE (1991)Lung cancer in women:the importance of smoking,family history of cancer,and medical history of respiratory disease.Cancer Res 51:4893-4897.
Eberly LE, Ockene J, Sherwin R, Yang L, Kuller L (2003) Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters.Int J Epidemiol 32: 592-599.
Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC (2003) Lung function and mortality in the United States:data from the First National Health and Nutrition Examination Survey follow up study.Thorax 58:388-393.
Skillrud DM, Offord KP, Miller RD (1986)Higher risk of lung cancer in chronic obstructive pulmonary disease.A prospective, matched,controlled study.Ann Intern Med 105:503-507.
Mannino DM (2002)COPD:epidemiology,prevalence,morbidity and mortality,and disease heterogeneity.Chest 121:121S-126S.
Barr RG, Herbstman J, Speizer FE, Camargo CA Jr (2002) Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses.Am J Epidemiol 155:965-971.
Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B (2002) Modeling smoking history:a comparison of different approaches.Am J Epidemiol 156:813-823.
Yang P, Wentzlaff KA, Katzmann JA,et al.(1999)Alpha1-antitrypsin de ciency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 8:461-465.
Piquette CA, Rennard SI, Snider GL (2000)Chronic bronchitis and emphysema.In:Nadel JA,(ed.),Textbook of Respiratory Medicine.Philadelphia: W.B.Saunders Company,pp.1187-1217.
Cohen BH, Diamond EL, Graves CG,et al.(1977)A common familial component in lung cancer and chronic obstructive pulmonary disease.Lancet 2:523-526.
Tager I, Tishler PV, Rosner B, Speizer FE, Litt M (1978)Studies of the familial aggregation of chronic bronchitis and obstructive airways disease.Int J Epidemiol 7:55-62.
Higgins M, Keller J (1975)Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capac-ity.J Chronic Dis 28:239-251.
Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K (1977) Familial prevalence of chronic obstructive pulmonary disease in a matched pair study.Am J Med 63:336-342.
Khoury MJ, Beaty TH, Newill CA, Bryant S, Cohen BH (1986) Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol 15:65-72.
Silverman EK, Chapman HA, Drazen JM,et al.(1998)Genetic epidemiology of severe,early-onset chronic obstructive pulmonary disease.Risk to relatives for air flow obstruction and chronic bronchitis.Am J Respir Crit Care Med 157:1770-1778.
Cohen BH (1978)Is pulmonary dysfunction the common denominator for the multiple effects of cigarette smoking?Lancet 2:1024-1027.
Ames BN, Shigenaga MK, Gold LS (1993)DNA lesions,inducible DNA repair,and cell division:three key factors in mutagenesis and carcinogenesis.Environ Health Perspect 101 (Suppl.5):35-44.
Cohen SM, Ellwein LB (1990)Cell proliferation in carcinogenesis. Science 249:1007-1011.
London WT,McGlynn KA (1996)Liver cancer.In:Fraumeni JF Jr,ed.Cancer Epidemiology and Prevention.New York: Oxford University Press,pp.772-793.
Farrow DC, Vaughan TL, Sweeney C,et al.(2000)Gastroesoph-ageal relux disease,use of H2 receptor antagonists,and risk of esophageal and gastric cancer.Cancer Causes Control11:231-238.
Nomura A (1996)Stomach cancer.In:Fraumeni JF Jr,ed.Cancer Epidemiology and Prevention.New York: Oxford University Press,pp.707-724.
Schottenfeld D, Winawer SJ (1996)Cancers of the large intestine. In:Fraumeni JF Jr,ed.Cancer Epidemiology and Prevention.New York: Oxford University Press,pp.813-840.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Littman, A.J., Thornquist, M.D., White, E. et al. Prior Lung Disease and Risk of Lung Cancer in a Large Prospective Study. Cancer Causes Control 15, 819–827 (2004). https://doi.org/10.1023/B:CACO.0000043432.71626.45
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000043432.71626.45